ciprofloxacin and sitafloxacin

ciprofloxacin has been researched along with sitafloxacin in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (34.62)	18.2507
2000's	8 (30.77)	29.6817
2010's	9 (34.62)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atarashi, S; Hayakawa, I; Kawakami, K; Kimura, Y; Sato, K	1
Baroni, M; Cecchetti, V; Cianchetta, G; Cruciani, G; Mannhold, R	1
Black, JA; Hanson, ND; Hong, SG; Hossain, A; Moland, ES; Thomson, KS; Wickman, PA	1
Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Hamasuna, R; Jensen, JS; Osada, Y	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bera, S; Mondal, D	1
Carlyn, CJ; Doyle, LJ; Knapp, CC; Ludwig, MD; Washington, JA	1
Cormican, MG; Jones, RN; Marshall, SA	1
Korten, V; Murray, BE; Tomayko, JF	1
Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Marshall, SA; Murray, PR; Washington, JA	1
Hayakawa, I; Hohmura, M; Hoshino, K; Ishida, H; Kitamura, A; Nishino, T; Sato, K; Tanaka, M	1
Erdem, I; Korten, V; Murray, BE	1
Morrissey, I	1
Sanders, CC; Thomson, KS	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Pitkänen, S; Siitonen, A	1
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Yamamoto, Y; Yanagihara, K	1
Malithong, A; Phiboonbanakit, D; Santiwatanakul, S; Srisangchan, P; Srisurat, N; Susaengrat, W; Tantisiriwat, W; Thamlikitkul, V; Thunyaharn, S; Tiengrim, S	1
Deguchi, T; Ito, S; Kikuchi, M; Yasuda, M	1
Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M	1
Changkaew, K; Changkwanyeun, R; Kongsoi, S; Nakajima, C; Suthienkul, O; Suzuki, Y; Yokoyama, K	1
Changkaew, K; Changkwanyeun, R; Kim, H; Kongsoi, S; Nakajima, C; Suthienkul, O; Suzuki, Y; Tamura, Y; Usui, M; Yamaguchi, T; Yokoyama, K	1
Linasmita, P; Tantisiriwat, W	1

Reviews

1 review(s) available for ciprofloxacin and sitafloxacin

Article	Year
Insights of synthetic analogues of anti-leprosy agents. Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13 Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship	2019

Other Studies

25 other study(ies) available for ciprofloxacin and sitafloxacin

Article	Year
(Fluorocyclopropyl)quinolones. 2. Synthesis and Stereochemical structure-activity relationships of chiral 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents. Journal of medicinal chemistry, 1994, Sep-30, Volume: 37, Issue:20 Topics: Animals; Anti-Infective Agents; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Conformation; Molecular Structure; Quinolones; Rats; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship	1994
Chemometric studies on the bactericidal activity of quinolones via an extended VolSurf approach. Journal of medicinal chemistry, 2004, Jun-03, Volume: 47, Issue:12 Topics: Anti-Bacterial Agents; Enterococcus faecalis; Escherichia coli; Models, Molecular; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Quinolones; Staphylococcus aureus; Thermodynamics	2004
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Drug Resistance, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Microbial Sensitivity Tests; Quinolones	2007
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11 Topics: Microbial Sensitivity Tests; Mycoplasma genitalium; Polymerase Chain Reaction	2009
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Quinolones; Spiro Compounds	1995
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin). Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:1 Topics: Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fleroxacin; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Spiro Compounds	1995
DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli. Diagnostic microbiology and infectious disease, 1994, Volume: 20, Issue:1 Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Drug Resistance, Multiple; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Quinolones; Spiro Compounds	1994
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:6 Topics: Anti-Infective Agents; Bacteria, Aerobic; Cefixime; Cefotaxime; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones	1993
Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method. The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:6 Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; Culture Media; Culture Media, Serum-Free; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Kinetics; Levofloxacin; Metals; Microbial Sensitivity Tests; Microscopy, Electron; Ofloxacin; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Urine	1996
Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococci. Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Antagonism; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Enterococcus; Fluoroquinolones; Genetic Variation; Gentamicins; Lactams; Microbial Sensitivity Tests; Novobiocin; Quinolones; Rifampin	1996
Bactericidal index: a new way to assess quinolone bactericidal activity in vitro. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:6 Topics: Anti-Infective Agents; Ciprofloxacin; Enterococcus faecalis; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones	1997
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Quinolones	1998
In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility. Annals of clinical microbiology and antimicrobials, 2005, Sep-05, Volume: 4 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Salmonella enterica	2005
In vivo efficacy of sitafloxacin in a new murine model of non-typeable Haemophilus influenzae pneumonia by sterile intratracheal tube. International journal of antimicrobial agents, 2009, Volume: 34, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bronchioles; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Intubation, Intratracheal; Male; Mice; Pneumonia, Bacterial; Pulmonary Alveoli; Time Factors; Trachea; Treatment Outcome	2009
Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95 Suppl 2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Respiratory Tract Infections; Thailand; Urinary Tract Infections	2012
Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Topoisomerase II Inhibitors	2015
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:9 Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin	2015
Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium. Drug testing and analysis, 2016, Volume: 8, Issue:10 Topics: Amino Acid Substitution; Ciprofloxacin; DNA Gyrase; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Salmonella typhimurium	2016
Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni. Drug testing and analysis, 2016, Volume: 8, Issue:10 Topics: Anti-Bacterial Agents; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Quinolones; Recombinant Proteins; Structure-Activity Relationship; Topoisomerase II Inhibitors	2016
In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2017, Volume: 100, Issue:4 Topics: Academic Medical Centers; Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; In Vitro Techniques; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Stenotrophomonas maltophilia; Thailand; Urinary Tract Infections	2017